Biotech | January 07, 2022
Merck KGaA to acquire biopharma CDMO Exelead for $780 million
The transaction is expected to close in the first quarter of 2022
The transaction is expected to close in the first quarter of 2022
It is the generic version of molnupiravir
Biogen paid Ionis a US $ 60 million one-time upfront payment
The test kit is compatible with all standard Real-Time PCR machines with a test run time of 85 minutes. The result turnaround time, including sample collection and RNA extraction, is 130 minutes
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
It plans to deliver over 300 million doses to the Indian government
SK bioscience secures long-term license to supply the Novavax vaccine for the Korean market
Pfizer raises production projections from 80 million to 120 million courses of treatment in 2022, as a result of continued investments to support the manufacturing and distribution of Paxlovid
With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction1
Subscribe To Our Newsletter & Stay Updated
